Tag Archives: regenerative medicine

All About Peptides: Making the Most of Longevity Medicine’s Latest Development

All About Peptides: Making the Most of Longevity Medicine’s Latest Development

Powerful, precise, and increasingly influential, peptides are making their mark on regenerative medicine. These short chains of amino acids bind to receptors and trigger specific cellular responses, acting as messengers throughout the body. By mimicking natural signaling molecules that regulate tissue repair, inflammation, hormone balance, and cellular aging, peptides are emerging as one of the newest frontiers in regenerative medicine.

The latest peptide therapies offer more targeted effects with fewer systemic side effects across a growing range of applications, from wound healing and joint, tendon, and organ regeneration to neurological recovery, metabolic health, and healthy aging.

Continue reading

Regeneration Spotlight: Exosomes, Stem Cells, and Longevity

The global stem cell industry is expanding, as rapid technological and clinical advances reveal new uses and platforms that are reshaping the landscape of regenerative medicine. Already being explored as treatments for osteoarthritis and joint repair, chronic wounds and tissue injuries, hair restoration and skin rejuvenation, and inflammation-related disorders, stem cells and exosomes are increasingly at the forefront of exciting new medical breakthroughs.

Scientists in Zurich have shown that stem cell transplants in mice can reverse stroke damage by regenerating neurons, restoring motor functions, and even repairing blood vessels — treatments could soon be adapted for humans. Japan has approved ground-breaking stem-cell treatments for Parkinson’s and severe heart failure, with the therapies expected to reach patients within months. And around the world, stem cells and exosomes are being explored as possible solutions for conditions ranging from diabetes to multiple sclerosis to autism and beyond.

Continue reading

The Regenerative Medicine Market: Current State and Future Outlook

As the world continues to grapple with the COVID-19 pandemic, the importance of regenerative medicine, and its many facets ranging from vaccine development to novel therapeutics, is being highlighted. While the industry has been receiving increased attention from investment firms in recent years, the recent boost in financial support from governments across the globe as part of the novel coronavirus response is expected to further propel the market. Businesses based on regenerative medicine are experiencing a flood of cash and record valuations – all factors predicted to fuel the market surge in coming years.

Continue reading